5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.18▲ | 1.18▲ | 1.18▲ | 1.19▲ | 1.26▼ |
MA10 | 1.18▲ | 1.17▲ | 1.16▲ | 1.19▲ | 1.34▼ |
MA20 | 1.17▲ | 1.15▲ | 1.17▲ | 1.25▼ | 1.22▼ |
MA50 | 1.15▲ | 1.18▲ | 1.19▲ | 1.37▼ | 2.65▼ |
MA100 | 1.18▲ | 1.19▲ | 1.24▼ | 1.19▲ | 10.23▼ |
MA200 | 1.17▲ | 1.25▼ | 1.27▼ | 1.76▼ | 20.04▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.007▲ | 0.005▲ | -0.002▼ | 0.194▲ |
RSI | 69.555▲ | 61.615▲ | 56.928▲ | 45.347▼ | 38.737▼ |
STOCH | 41.111 | 77.500 | 81.944▲ | 37.918 | 18.974▼ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -77.660▼ | -73.999 |
CCI | 236.047▲ | 187.065▲ | 187.215▲ | -30.179 | -77.783 |
Wednesday, September 10, 2025 01:49 PM
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...
|
Tuesday, September 09, 2025 05:47 AM
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...
|
Friday, August 22, 2025 06:47 AM
CRANFORD, N.J., Aug. 22, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 1.205 | 1.205 | 1.205 | 1.205 | 8,701 |
16/09/25 | 1.16 | 1.20 | 1.145 | 1.17 | 182,664 |
15/09/25 | 1.18 | 1.19 | 1.13 | 1.14 | 289,082 |
12/09/25 | 1.20 | 1.21 | 1.18 | 1.21 | 161,755 |
11/09/25 | 1.20 | 1.25 | 1.19 | 1.20 | 188,870 |
10/09/25 | 1.21 | 1.23 | 1.1821 | 1.21 | 124,833 |
09/09/25 | 1.22 | 1.22 | 1.168 | 1.21 | 185,028 |
08/09/25 | 1.20 | 1.2343 | 1.16 | 1.22 | 216,779 |
05/09/25 | 1.15 | 1.23 | 1.13 | 1.23 | 270,627 |
04/09/25 | 1.24 | 1.24 | 1.10 | 1.15 | 556,168 |
|
|
||||
|
|
||||
|
|